HRS7415
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 14, 2026
A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=38 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Completed | N=67 ➔ 38 | Trial completion date: Oct 2023 ➔ Mar 2025 | Trial primary completion date: Feb 2023 ➔ Mar 2025
Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Oncology • Solid Tumor
April 08, 2022
A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=67 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1